1 Ophthalmol Drug Market Overview 1.1 Product Overview and Scope of Ophthalmol Drug 1.2 Ophthalmol Drug Segment by Type 1.2.1 Global Ophthalmol Drug Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Retinal disorders drugs 1.2.3 Allergic, inflammatory and infective drugs 1.2.4 Glaucoma drugs 1.2.5 Dry eye drugs 1.3 Ophthalmol Drug Segment by Application 1.3.1 Ophthalmol Drug Sales Comparison by Application: 2020 VS 2026 1.3.2 Glaucoma 1.3.3 Dry eye syndrome 1.3.4 Retinal diseases 1.3.5 Other ophthalmic indications 1.4 Global Ophthalmol Drug Market Size Estimates and Forecasts 1.4.1 Global Ophthalmol Drug Revenue 2015-2026 1.4.2 Global Ophthalmol Drug Sales 2015-2026 1.4.3 Ophthalmol Drug Market Size by Region: 2020 Versus 2026 1.5 Ophthalmol Drug Industry 1.6 Ophthalmol Drug Market Trends 2 Global Ophthalmol Drug Market Competition by Manufacturers 2.1 Global Ophthalmol Drug Sales Market Share by Manufacturers (2015-2020) 2.2 Global Ophthalmol Drug Revenue Share by Manufacturers (2015-2020) 2.3 Global Ophthalmol Drug Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Ophthalmol Drug Manufacturing Sites, Area Served, Product Type 2.5 Ophthalmol Drug Market Competitive Situation and Trends 2.5.1 Ophthalmol Drug Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Ophthalmol Drug Players (Opinion Leaders) 3 Ophthalmol Drug Retrospective Market Scenario by Region 3.1 Global Ophthalmol Drug Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Ophthalmol Drug Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Ophthalmol Drug Market Facts & Figures by Country 3.3.1 North America Ophthalmol Drug Sales by Country 3.3.2 North America Ophthalmol Drug Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Ophthalmol Drug Market Facts & Figures by Country 3.4.1 Europe Ophthalmol Drug Sales by Country 3.4.2 Europe Ophthalmol Drug Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Ophthalmol Drug Market Facts & Figures by Region 3.5.1 Asia Pacific Ophthalmol Drug Sales by Region 3.5.2 Asia Pacific Ophthalmol Drug Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Ophthalmol Drug Market Facts & Figures by Country 3.6.1 Latin America Ophthalmol Drug Sales by Country 3.6.2 Latin America Ophthalmol Drug Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Ophthalmol Drug Market Facts & Figures by Country 3.7.1 Middle East and Africa Ophthalmol Drug Sales by Country 3.7.2 Middle East and Africa Ophthalmol Drug Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Ophthalmol Drug Historic Market Analysis by Type 4.1 Global Ophthalmol Drug Sales Market Share by Type (2015-2020) 4.2 Global Ophthalmol Drug Revenue Market Share by Type (2015-2020) 4.3 Global Ophthalmol Drug Price Market Share by Type (2015-2020) 4.4 Global Ophthalmol Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Ophthalmol Drug Historic Market Analysis by Application 5.1 Global Ophthalmol Drug Sales Market Share by Application (2015-2020) 5.2 Global Ophthalmol Drug Revenue Market Share by Application (2015-2020) 5.3 Global Ophthalmol Drug Price by Application (2015-2020) 6 Company Profiles and Key Figures in Ophthalmol Drug Business 6.1 Novartis 6.1.1 Corporation Information 6.1.2 Novartis Description, Business Overview and Total Revenue 6.1.3 Novartis Ophthalmol Drug Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Novartis Products Offered 6.1.5 Novartis Recent Development 6.2 Allergan 6.2.1 Allergan Corporation Information 6.2.2 Allergan Description, Business Overview and Total Revenue 6.2.3 Allergan Ophthalmol Drug Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Allergan Products Offered 6.2.5 Allergan Recent Development 6.3 Roche 6.3.1 Roche Corporation Information 6.3.2 Roche Description, Business Overview and Total Revenue 6.3.3 Roche Ophthalmol Drug Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Roche Products Offered 6.3.5 Roche Recent Development 6.4 Valeant 6.4.1 Valeant Corporation Information 6.4.2 Valeant Description, Business Overview and Total Revenue 6.4.3 Valeant Ophthalmol Drug Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Valeant Products Offered 6.4.5 Valeant Recent Development 6.5 Regeneron 6.5.1 Regeneron Corporation Information 6.5.2 Regeneron Description, Business Overview and Total Revenue 6.5.3 Regeneron Ophthalmol Drug Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Regeneron Products Offered 6.5.5 Regeneron Recent Development 6.6 Santen 6.6.1 Santen Corporation Information 6.6.2 Santen Description, Business Overview and Total Revenue 6.6.3 Santen Ophthalmol Drug Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Santen Products Offered 6.6.5 Santen Recent Development 6.7 Bayer 6.6.1 Bayer Corporation Information 6.6.2 Bayer Description, Business Overview and Total Revenue 6.6.3 Bayer Ophthalmol Drug Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Bayer Products Offered 6.7.5 Bayer Recent Development 6.8 Pfizer 6.8.1 Pfizer Corporation Information 6.8.2 Pfizer Description, Business Overview and Total Revenue 6.8.3 Pfizer Ophthalmol Drug Sales, Revenue and Gross Margin (2015-2020) 6.8.4 Pfizer Products Offered 6.8.5 Pfizer Recent Development 6.9 Senju 6.9.1 Senju Corporation Information 6.9.2 Senju Description, Business Overview and Total Revenue 6.9.3 Senju Ophthalmol Drug Sales, Revenue and Gross Margin (2015-2020) 6.9.4 Senju Products Offered 6.9.5 Senju Recent Development 6.10 Akorn 6.10.1 Akorn Corporation Information 6.10.2 Akorn Description, Business Overview and Total Revenue 6.10.3 Akorn Ophthalmol Drug Sales, Revenue and Gross Margin (2015-2020) 6.10.4 Akorn Products Offered 6.10.5 Akorn Recent Development 7 Ophthalmol Drug Manufacturing Cost Analysis 7.1 Ophthalmol Drug Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Ophthalmol Drug 7.4 Ophthalmol Drug Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Ophthalmol Drug Distributors List 8.3 Ophthalmol Drug Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Ophthalmol Drug Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Ophthalmol Drug by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Ophthalmol Drug by Type (2021-2026) 10.2 Ophthalmol Drug Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Ophthalmol Drug by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Ophthalmol Drug by Application (2021-2026) 10.3 Ophthalmol Drug Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Ophthalmol Drug by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Ophthalmol Drug by Region (2021-2026) 10.4 North America Ophthalmol Drug Estimates and Projections (2021-2026) 10.5 Europe Ophthalmol Drug Estimates and Projections (2021-2026) 10.6 Asia Pacific Ophthalmol Drug Estimates and Projections (2021-2026) 10.7 Latin America Ophthalmol Drug Estimates and Projections (2021-2026) 10.8 Middle East and Africa Ophthalmol Drug Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Ophthalmol Drug Sales (K MT) Growth Rate Comparison by Type (2015-2026) Table 2. Global Ophthalmol Drug Sales (K MT) Comparison by Application: 2020 VS 2026 Table 3. Global Ophthalmol Drug Market Size by Type (K MT) (US$ Million) (2020 VS 2026) Table 4. Global Key Ophthalmol Drug Manufacturers Covered in This Study Table 5. Global Ophthalmol Drug Sales (K MT) by Manufacturers (2015-2020) Table 6. Global Ophthalmol Drug Sales Share by Manufacturers (2015-2020) Table 7. Global Ophthalmol Drug Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Ophthalmol Drug Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Ophthalmol Drug Average Price (USD/MT) of Key Manufacturers (2015-2020) Table 10. Manufacturers Ophthalmol Drug Sales Sites and Area Served Table 11. Manufacturers Ophthalmol Drug Product Types Table 12. Global Ophthalmol Drug Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Ophthalmol Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ophthalmol Drug as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Ophthalmol Drug Players Table 16. Global Ophthalmol Drug Sales (K MT) by Region (2015-2020) Table 17. Global Ophthalmol Drug Sales Market Share by Region (2015-2020) Table 18. Global Ophthalmol Drug Revenue (Million US$) by Region (2015-2020) Table 19. Global Ophthalmol Drug Revenue Market Share by Region (2015-2020) Table 20. North America Ophthalmol Drug Sales by Country (2015-2020) (K MT) Table 21. North America Ophthalmol Drug Sales Market Share by Country (2015-2020) Table 22. North America Ophthalmol Drug Revenue by Country (2015-2020) (US$ Million) Table 23. North America Ophthalmol Drug Revenue Market Share by Country (2015-2020) Table 24. Europe Ophthalmol Drug Sales by Country (2015-2020) (K MT) Table 25. Europe Ophthalmol Drug Sales Market Share by Country (2015-2020) Table 26. Europe Ophthalmol Drug Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Ophthalmol Drug Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Ophthalmol Drug Sales by Region (2015-2020) (K MT) Table 29. Asia Pacific Ophthalmol Drug Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Ophthalmol Drug Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Ophthalmol Drug Revenue Market Share by Region (2015-2020) Table 32. Latin America Ophthalmol Drug Sales by Country (2015-2020) (K MT) Table 33. Latin America Ophthalmol Drug Sales Market Share by Country (2015-2020) Table 34. Latin America Ophthalmol Drug Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Ophthalmol Drug Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Ophthalmol Drug Sales by Country (2015-2020) (K MT) Table 37. Middle East and Africa Ophthalmol Drug Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Ophthalmol Drug Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Ophthalmol Drug Revenue Market Share by Country (2015-2020) Table 40. Global Ophthalmol Drug Sales (K MT) by Type (2015-2020) Table 41. Global Ophthalmol Drug Sales Share by Type (2015-2020) Table 42. Global Ophthalmol Drug Revenue (Million US$) by Type (2015-2020) Table 43. Global Ophthalmol Drug Revenue Share by Type (2015-2020) Table 44. Global Ophthalmol Drug Price (USD/MT) by Type (2015-2020) Table 45. Global Ophthalmol Drug Sales (K MT) by Application (2015-2020) Table 46. Global Ophthalmol Drug Sales Market Share by Application (2015-2020) Table 47. Global Ophthalmol Drug Sales Growth Rate by Application (2015-2020) Table 48. Novartis Ophthalmol Drug Corporation Information Table 49. Novartis Description and Business Overview Table 50. Novartis Ophthalmol Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 51. Novartis Main Product Table 52. Novartis Recent Development Table 53. Allergan Ophthalmol Drug Corporation Information Table 54. Allergan Corporation Information Table 55. Allergan Ophthalmol Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 56. Allergan Main Product Table 57. Allergan Recent Development Table 58. Roche Ophthalmol Drug Corporation Information Table 59. Roche Corporation Information Table 60. Roche Ophthalmol Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 61. Roche Main Product Table 62. Roche Recent Development Table 63. Valeant Ophthalmol Drug Corporation Information Table 64. Valeant Corporation Information Table 65. Valeant Ophthalmol Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 66. Valeant Main Product Table 67. Valeant Recent Development Table 68. Regeneron Ophthalmol Drug Corporation Information Table 69. Regeneron Corporation Information Table 70. Regeneron Ophthalmol Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 71. Regeneron Main Product Table 72. Regeneron Recent Development Table 73. Santen Ophthalmol Drug Corporation Information Table 74. Santen Corporation Information Table 75. Santen Ophthalmol Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 76. Santen Main Product Table 77. Santen Recent Development Table 78. Bayer Ophthalmol Drug Corporation Information Table 79. Bayer Corporation Information Table 80. Bayer Ophthalmol Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 81. Bayer Main Product Table 82. Bayer Recent Development Table 83. Pfizer Ophthalmol Drug Corporation Information Table 84. Pfizer Corporation Information Table 85. Pfizer Ophthalmol Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 86. Pfizer Main Product Table 87. Pfizer Recent Development Table 88. Senju Ophthalmol Drug Corporation Information Table 89. Senju Corporation Information Table 90. Senju Ophthalmol Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 91. Senju Main Product Table 92. Senju Recent Development Table 93. Akorn Ophthalmol Drug Corporation Information Table 94. Akorn Corporation Information Table 95. Akorn Ophthalmol Drug Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 96. Akorn Main Product Table 97. Akorn Recent Development Table 98. Sales Base and Market Concentration Rate of Raw Material Table 99. Key Suppliers of Raw Materials Table 100. Ophthalmol Drug Distributors List Table 101. Ophthalmol Drug Customers List Table 102. Market Key Trends Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 104. Key Challenges Table 105. Global Ophthalmol Drug Sales (K MT) Forecast by Type (2021-2026) Table 106. Global Ophthalmol Drug Sales Market Share Forecast by Type (2021-2026) Table 107. Global Ophthalmol Drug Revenue (Million US$) Forecast by Type (2021-2026) Table 108. Global Ophthalmol Drug Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 109. Global Ophthalmol Drug Sales (K MT) Forecast by Application (2021-2026) Table 110. Global Ophthalmol Drug Revenue (Million US$) Forecast by Application (2021-2026) Table 111. Global Ophthalmol Drug Sales (K MT) Forecast by Region (2021-2026) Table 112. Global Ophthalmol Drug Sales Market Share Forecast by Region (2021-2026) Table 113. Global Ophthalmol Drug Revenue Forecast by Region (2021-2026) (US$ Million) Table 114. Global Ophthalmol Drug Revenue Market Share Forecast by Region (2021-2026) Table 115. Research Programs/Design for This Report Table 116. Key Data Information from Secondary Sources Table 117. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Ophthalmol Drug Figure 2. Global Ophthalmol Drug Sales Market Share by Type: 2020 VS 2026 Figure 3. Retinal disorders drugs Product Picture Figure 4. Allergic, inflammatory and infective drugs Product Picture Figure 5. Glaucoma drugs Product Picture Figure 6. Dry eye drugs Product Picture Figure 7. Global Ophthalmol Drug Consumption Market Share by Application: 2020 VS 2026 Figure 8. Glaucoma Figure 9. Dry eye syndrome Figure 10. Retinal diseases Figure 11. Other ophthalmic indications Figure 12. Global Ophthalmol Drug Market Size 2015-2026 (US$ Million) Figure 13. Global Ophthalmol Drug Sales Capacity (K MT) (2015-2026) Figure 14. Global Ophthalmol Drug Market Size Market Share by Region: 2020 Versus 2026 Figure 15. Ophthalmol Drug Sales Share by Manufacturers in 2020 Figure 16. Global Ophthalmol Drug Revenue Share by Manufacturers in 2019 Figure 17. The Global 5 and 10 Largest Players: Market Share by Ophthalmol Drug Revenue in 2019 Figure 18. Ophthalmol Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 19. Global Ophthalmol Drug Sales Market Share by Region (2015-2020) Figure 20. Global Ophthalmol Drug Sales Market Share by Region in 2019 Figure 21. Global Ophthalmol Drug Revenue Market Share by Region (2015-2020) Figure 22. Global Ophthalmol Drug Revenue Market Share by Region in 2019 Figure 23. North America Ophthalmol Drug Sales Market Share by Country in 2019 Figure 24. North America Ophthalmol Drug Revenue Market Share by Country in 2019 Figure 25. U.S. Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT) Figure 26. U.S. Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 27. Canada Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT) Figure 28. Canada Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 29. Europe Ophthalmol Drug Sales Market Share by Country in 2019 Figure 30. Europe Ophthalmol Drug Revenue Market Share by Country in 2019 Figure 31. Germany Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT) Figure 32. Germany Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. France Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT) Figure 34. France Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. U.K. Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT) Figure 36. U.K. Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Italy Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT) Figure 38. Italy Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Russia Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT) Figure 40. Russia Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. Asia Pacific Ophthalmol Drug Sales Market Share by Region in 2019 Figure 42. Asia Pacific Ophthalmol Drug Revenue Market Share by Region in 2019 Figure 43. China Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT) Figure 44. China Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. Japan Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT) Figure 46. Japan Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. South Korea Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT) Figure 48. South Korea Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. India Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT) Figure 50. India Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Australia Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT) Figure 52. Australia Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Taiwan Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT) Figure 54. Taiwan Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Indonesia Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT) Figure 56. Indonesia Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Thailand Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT) Figure 58. Thailand Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Malaysia Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT) Figure 60. Malaysia Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Philippines Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT) Figure 62. Philippines Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Vietnam Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT) Figure 64. Vietnam Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Latin America Ophthalmol Drug Sales Market Share by Country in 2019 Figure 66. Latin America Ophthalmol Drug Revenue Market Share by Country in 2019 Figure 67. Mexico Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT) Figure 68. Mexico Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Brazil Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT) Figure 70. Brazil Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Argentina Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT) Figure 72. Argentina Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Middle East and Africa Ophthalmol Drug Sales Market Share by Country in 2019 Figure 74. Middle East and Africa Ophthalmol Drug Revenue Market Share by Country in 2019 Figure 75. Turkey Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT) Figure 76. Turkey Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Saudi Arabia Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT) Figure 78. Saudi Arabia Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. U.A.E Ophthalmol Drug Sales Growth Rate (2015-2020) (K MT) Figure 80. U.A.E Ophthalmol Drug Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Sales Market Share of Ophthalmol Drug by Type (2015-2020) Figure 82. Sales Market Share of Ophthalmol Drug by Type in 2019 Figure 83. Revenue Share of Ophthalmol Drug by Type (2015-2020) Figure 84. Revenue Market Share of Ophthalmol Drug by Type in 2019 Figure 85. Global Ophthalmol Drug Sales Growth by Type (2015-2020) (K MT) Figure 86. Global Ophthalmol Drug Sales Market Share by Application (2015-2020) Figure 87. Global Ophthalmol Drug Sales Market Share by Application in 2019 Figure 88. Global Revenue Share of Ophthalmol Drug by Application (2015-2020) Figure 89. Global Revenue Share of Ophthalmol Drug by Application in 2020 Figure 90. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Allergan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Valeant Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Regeneron Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Santen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Bayer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Senju Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Akorn Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. Price Trend of Key Raw Materials Figure 101. Manufacturing Cost Structure of Ophthalmol Drug Figure 102. Manufacturing Process Analysis of Ophthalmol Drug Figure 103. Ophthalmol Drug Industrial Chain Analysis Figure 104. Channels of Distribution Figure 105. Distributors Profiles Figure 106. Porter's Five Forces Analysis Figure 107. North America Ophthalmol Drug Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 108. North America Ophthalmol Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 109. Europe Ophthalmol Drug Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 110. Europe Ophthalmol Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 111. Latin America Ophthalmol Drug Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 112. Latin America Ophthalmol Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 113. Middle East and Africa Ophthalmol Drug Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 114. Middle East and Africa Ophthalmol Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 115. Asia Pacific Ophthalmol Drug Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 116. Asia Pacific Ophthalmol Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 117. Bottom-up and Top-down Approaches for This Report Figure 118. Data Triangulation Figure 119. Key Executives Interviewed

Novartis Allergan Roche Valeant Regeneron Santen Bayer Pfizer Senju Akorn